Work

ASO Visual Abstract: Local-Regional Recurrence Following Neoadjuvant Endocrine Therapy – Data from ACOSOG Z1031 (Alliance), a Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women with Estrogen Receptor–Positive Clinical Stage 2–3 Breast Cancer

Year: 2023

Type: article

Source: Annals of Surgical Oncology

DOI: 10.1245/s10434-023-13149-4

Authors: Kelly K. Hunt, Vera J. Suman, Hannah F. Wingate, A. Marilyn Leitch, Gary Unzeitig, Judy C. Boughey, Funda Meric-Bernstam, Matthew J. Ellis, John A. Olson

Institutions: The University of Texas MD Anderson Cancer Center, Mayo Clinic, The University of Texas Southwestern Medical Center, Doctors Hospital of Laredo, Baylor College of Medicine, University of Maryland, Baltimore, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4319294152

FWCI:

Cites:

Cited by:

Related to: 10